Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
Operator-turned-venture investor with experience sourcing and scaling early-stage technology companies, focused on fintech, consumer platforms and climate-tech. Maggie Hartness combines operating leadership, board experience and sector-focused investing to evaluate product-market fit, unit economics and growth capital needs. Known for hands-on portfolio support, strategic go-to-market counsel and follow-on capital mobilization; frequently advises founders on metrics-driven scaling and capital strategy.
| Trades 1696 | Longs Won 1237/1696 72% | Profit Factor 9.66 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $786,270.72 |
| Average Win $184,351.44 | Best Trade (Aug 28) $19.1M | Sharpe Ratio -13.01 |
| Average Loss -$51,421.82 | Worst Trade (Jun 29) -$1.23M | Z-Score 3.38 (99.93%) |
| Commissions $0 | Avg. Trade Length 2y 3m 3w 6d | Expectancy $120,542.52 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,000 | 7,200 | 6,400 | 5,600 | 4,800 | 4,000 | 3,200 | 2,400 | 1,600 | 800 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 109,796 | $24.9M | $33.92M | - | $9.02M | 36.22% | -7.354% |
ABBV AbbVie Inc. | 1,014 | $236,103.23 | $254,453.16 | - | $18,349.93 | 7.77% | -2.513% |
ABT Abbott Laboratories | 19,655 | $1.88M | $2.08M | - | $196,147.74 | 10.43% | +0.085% |
ADI Analog Devices, Inc. | 708 | $225,243 | $260,126.28 | - | $34,883.28 | 15.49% | +0.202% |
AJG Arthur J. Gallagher & Co. | 10,541 | $1.44M | $2.63M | - | $1.19M | 82.94% | -2.745% |
AMAT Applied Materials, Inc. | 2,464 | $1.78M | $1.25M | - | -$530,573.1 | -29.78% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,490 | $865,556 | $709,463.49 | - | -$156,092.51 | -18.03% | -1.904% |
AME Ametek Inc. | 950 | $180,444.61 | $229,624.51 | - | $49,179.9 | 27.25% | +0.708% |
AMGN Amgen Inc. | 1,969 | $523,207.59 | $758,380.04 | - | $235,172.45 | 44.95% | -0.64% |
AMZN Amazon.com Inc | 28,616 | $5.71M | $7.77M | - | $2.06M | 36.13% | +15.321% |
AVDE Avantis International Equity ETF | 71,796 | $6.12M | $6.55M | - | $429,649.97 | 7.02% | -0.458% |
AVDV Avantis International Small Cap Value ETF | 37,372 | $3.75M | $3.91M | - | $159,670.72 | 4.26% | -0.476% |
AVGO Broadcom Inc. | 8,734 | $942,403.7 | $3.4M | - | $2.46M | 260.78% | +0.371% |
AVY Avery Dennison Corporation | 2,240 | $228,189.06 | $380,195.2 | - | $152,006.14 | 66.61% | -2.912% |
AZN AstraZeneca PLC American Depositary Shares | 1,623 | $307,753 | $275,325.72 | - | -$32,427.28 | -10.54% | -0.992% |
BAC Bank of America Corporation | 59,162 | $1.99M | $3.67M | - | $1.67M | 83.84% | +0.356% |
BKR Baker Hughes Company | 6,484 | $391,086 | $392,217.16 | - | $1,131.16 | 0.29% | +0.985% |
BLK BlackRock, Inc. | 605 | $572,758.32 | $659,685.96 | - | $86,927.64 | 15.18% | -0.727% |
BRK-B Berkshire Hathaway Inc. | 668 | $339,643.58 | $341,708.72 | - | $2,065.14 | 0.61% | +0.365% |
BSCR Invesco BulletShares 2027 Corporate Bond ETF | 18,058 | $355,728.91 | $354,027.09 | - | -$1,701.82 | -0.48% | 0.0 |